Mediracer weekly updates

NEWS AND BLOG




Georg Meissner started as a CEO in Mediracer Ltd. and Head Instruments Ltd. at the end of April. Before this he has worked at Specim, Spectral Imaging Oy, as Managing Director and has lead the company successfully to a substantial growth. Prior to this he worked at Nokia in various product and program management roles, including Director of Roadmapping and Concepting.

Georg Meissner holds a Ph.D. in Chemistry from Philipps-Universität Marburg, Germany, and he is both German and Finnish national.

“Mediracer and Head Instruments are two independent companies, but this double position as CEO enables better co-operation between companies from the same business sector”, says Dr. Meissner.

Mediracer’s previous CEO Yoko Keränen will continue in the company as Business Development Director. Head Instrument’s previous CEO and co-founder Jani Katisko will continue as Specialist.

Contact Dr. Georg Meissner:

georg.meissner@mediracer.com // tel. +358 40 517 0182

Head Instruments Ltd. is Oulu, Finland, based startup developing surgical technologies. Head Instruments enables the research, clinical testing and productization of advanced surgical technologies. www.headinstruments.com

Mediracer Ltd. developes Point of Care products in the field of clinical neurophysiology for patient examinations adapted to the needs of primary health care. The target is to develop reliable and cost-effective products for examination of the most common neurophysiological disorders on primary health care level, requiring only a short training for the operators. Mediracer is part of Head Invest Group. www.mediracer.com



Georg Meissner started as a CEO in Mediracer Ltd. and Head Instruments Ltd. at the end of April. Before this he has worked at Specim, Spectral Imaging Oy, as Managing Director and has lead the company successfully to a substantial growth. Prior to this he worked at Nokia in various product and program management roles, including Director of Roadmapping and Concepting.

Georg Meissner holds a Ph.D. in Chemistry from Philipps-Universität Marburg, Germany, and he is both German and Finnish national.

“Mediracer and Head Instruments are two independent companies, but this double position as CEO enables better co-operation between companies from the same business sector”, says Dr. Meissner.

Mediracer’s previous CEO Yoko Keränen will continue in the company as Business Development Director. Head Instrument’s previous CEO and co-founder Jani Katisko will continue as Specialist.

Contact Dr. Georg Meissner:

georg.meissner@mediracer.com // tel. +358 40 517 0182

Head Instruments Ltd. is Oulu, Finland, based startup developing surgical technologies. Head Instruments enables the research, clinical testing and productization of advanced surgical technologies. www.headinstruments.com

Mediracer Ltd. developes Point of Care products in the field of clinical neurophysiology for patient examinations adapted to the needs of primary health care. The target is to develop reliable and cost-effective products for examination of the most common neurophysiological disorders on primary health care level, requiring only a short training for the operators. Mediracer is part of Head Invest Group. www.mediracer.com



Georg Meissner started as a CEO in Mediracer Ltd. and Head Instruments Ltd. at the end of April. Before this he has worked at Specim, Spectral Imaging Oy, as Managing Director and has lead the company successfully to a substantial growth. Prior to this he worked at Nokia in various product and program management roles, including Director of Roadmapping and Concepting.

Georg Meissner holds a Ph.D. in Chemistry from Philipps-Universität Marburg, Germany, and he is both German and Finnish national.

“Mediracer and Head Instruments are two independent companies, but this double position as CEO enables better co-operation between companies from the same business sector”, says Dr. Meissner.

Mediracer’s previous CEO Yoko Keränen will continue in the company as Business Development Director. Head Instrument’s previous CEO and co-founder Jani Katisko will continue as Specialist.

Contact Dr. Georg Meissner:

georg.meissner@mediracer.com // tel. +358 40 517 0182

Head Instruments Ltd. is Oulu, Finland, based startup developing surgical technologies. Head Instruments enables the research, clinical testing and productization of advanced surgical technologies. www.headinstruments.com

Mediracer Ltd. developes Point of Care products in the field of clinical neurophysiology for patient examinations adapted to the needs of primary health care. The target is to develop reliable and cost-effective products for examination of the most common neurophysiological disorders on primary health care level, requiring only a short training for the operators. Mediracer is part of Head Invest Group. www.mediracer.com



新しいWindows版(OS 10)Mediracer検査のソフトウェアは、快適なユーザーインターフェイスと、迅速な検査プロセスにより、先生方への多くの利点をもたらし、新たな遠隔解析ソリューションとともに、神経生理学医による検査結果の解析をローカルに提供することが可能です。

新しいMediracerソフトウェアの機能は次の通りです:

〇 Windowsプラットフォームは、データの処理や転送が容易です。

〇 データの保存や印刷を、組織内の複数のコンピュータにプログラムをインストールしてご活用頂けます。

〇 検査ごとの時間が短縮され、検査工程全体が迅速化されます。

〇 簡略化された検査プロセスにより、検査者を的確に導きます。

〇 アルゴリズム方法が変わり、神経応答の質が改善されております。

〇 神経生理学医による検査結果解析のリモート解析ソリューションをローカルに提供します。

〇 拡張レポートは、テスト結果を明確かつ多様に表示します。

〇 より広範囲な神経生理学的検査をサポートします。

- 感覚神経研究 ー

○ 手根管症候群

○ 肘部管症候群

○ 正中神経伝導速度

○ 尺骨神経伝導速度

○ 腓腹神経伝導速度

○ 深腓骨伝導速度

○ 浅腓骨伝導速度

- 運動神経研究 ー

○ 正中神経遠位潜時

○ 正中神経伝導速度

○ 尺骨神経伝導速度

○ 脛骨神経伝導速度



New Windows-based (OS 10) Mediracer examination software with an easy and pleasant user interface and faster testing process, brings many benefits for the user. Also, along with a renewed remote analysis solution the neurophysiologists are able to provide interpretations for Mediracer test results locally.

The features of the new Mediracer software include:

  • Windows platform facilitates data processing and transfer, e.g. saving and printing data
    • program can be installed onto multiple computers inside an organisation
  • Time per test shortens expediting the whole testing process
  • Simplified testing process guides the person conducting the test
  • Excellent and noiceless quality of nerve responses due to enhanced algorithmic methods in the software
  • Remote analysis solution for neurophysiology doctors for interpreting Mediracer test results locally
  • Extended reporting depicts the test results clearly and diversely
  • The software supports and enables more extensive neurophysiological examinations:
    • SENSORY STUDIES
      • carpal tunnel syndrome
      • ulnar entrapment at the elbow
      • median conduction velocity
      • ulnar conduction velocity
      • sural conduction velocity
      • peroneal deep conduction velocity
      • peroneal superficial conduction velocity
    • MOTOR STUDIES
      • median distal latency
      • median conduction velocity
      • ulnar conduction velocity
      • tibial conduction velocity





Get in touch

Contact us now

Mediracer Ltd was founded in 2002 to develop Point of Care products in the field of clinical neurophysiology for patient examinations adapted to the needs of primary health care.


Email

info@mediracer.com



Phone Number

+358 45 899 2626



Follow us

Our Activity

Provide high quality products to improve our solutions and make them more innovative to contribute to improvement of health care



Copyright by Mediracer 2019